Recruitment has started at all clinical centers
We are pleased to announce that all clinical trial centers, located in Kenya,
Tanzania, Uganda, South Africa and Gabon, have started their recruitment and are actively enrolling participants into the pivotal phase III trial (priMe) of the
novel tuberculosis vaccine VPM1002.
We thank all consortium partners for the effort in achieving this milestone!